Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases (original) (raw)

• Alvarez MJ, Prada F, Salvatierra E, Bravo AI, Lutzky VP, Carbone C et al. (2005). Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity. Cancer Res 65: 5123–5132.
  Article CAS PubMed Google Scholar
• Barker TH, Baneyx G, Cardo-Vila M, Workman GA, Weaver M, Menon PM et al. (2005). SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J Biol Chem 280: 36483–36493.
  Article CAS PubMed Google Scholar
• Chicoine MR, Silbergeld DL . (1995). Assessment of brain tumor cell motility in vivo and in vitro. J Neurosurg 82: 615–622.
  Article CAS PubMed Google Scholar
• Datta SR, Brunet A, Greenberg ME . (1999). Cellular survival: a play in three Akts. Genes Dev 13: 2905–2927.
  Article CAS PubMed Google Scholar
• Framson PE, Sage EH . (2004). SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 92: 679–690.
  Article CAS PubMed Google Scholar
• Giese A, Bjerkvig R, Berens ME, Westphal M . (2003). Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21: 1624–1636.
  Article CAS PubMed Google Scholar
• Gradishar WJ . (2006). Albumin-bound paclitaxel: a next-generation taxane. Expert Opin Pharmacother 7: 1041–1053.
  Article CAS PubMed Google Scholar
• Hecker TP, Grammer JR, Gillespie GY, Stewart Jr J, Gladson CL . (2002). Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples. Cancer Res 62: 2699–2707.
  CAS PubMed Google Scholar
• Jones C, Mackay A, Grigoriadis A, Cossu A, Reis-Filho JS, Fulford L et al. (2004). Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. Cancer Res 64: 3037–3045.
  Article CAS PubMed Google Scholar
• Kenney J, Schmiedl U, Maravilla K, Starr F, Graham M, Spence A et al. (1992). Measurement of blood–brain barrier permeability in a tumor model using magnetic resonance imaging with gadolinium-DTPA. Magn Reson Med 27: 68–75.
  Article CAS PubMed Google Scholar
• Koblinski JE, Kaplan-Singer BR, VanOsdol SJ, Wu M, Engbring JA, Wang S et al. (2005). Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. Cancer Res 65: 7370–7377.
  Article CAS PubMed Google Scholar
• Lal A, Lash AE, Altschul SF, Velculescu V, Zhang L, McLendon RE et al. (1999). A public database for gene expression in human cancers. Cancer Res 59: 5403–5407.
  CAS PubMed Google Scholar
• Ledda MF, Adris S, Bravo AI, Kairiyama C, Bover L, Chernajovsky Y et al. (1997). Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat Med 3: 171–176.
  Article CAS PubMed Google Scholar
• Mundlos S, Schwahn B, Reichert T, Zabel B . (1992). Distribution of osteonectin mRNA and protein during human embryonic and fetal development. J Histochem Cytochem 40: 283–291.
  Article CAS PubMed Google Scholar
• Obara S, Nakata M, Takeshima H, Katagiri H, Asano T, Oka Y et al. (2004). Integrin-linked kinase (ILK) regulation of the cell viability in PTEN mutant glioblastoma and in vitro inhibition by the specific COX-2 inhibitor NS-398. Cancer Lett 208: 115–122.
  Article CAS PubMed Google Scholar
• Rempel SA, Golembieski WA, Ge S, Lemke N, Elisevich K, Mikkelsen T et al. (1998). SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. J Neuropathol Exp Neurol 57: 1112–1121.
  Article CAS PubMed Google Scholar
• Rich JN, Hans C, Jones B, Iversen ES, McLendon RE, Rasheed BK et al. (2005). Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 65: 4051–4058.
  Article CAS PubMed Google Scholar
• Rich JN, Shi Q, Hjelmeland M, Cummings TJ, Kuan CT, Bigner DD et al. (2003). Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem 278: 15951–15957.
  Article CAS PubMed Google Scholar
• Schultz C, Lemke N, Ge S, Golembieski WA, Rempel SA . (2002). Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Cancer Res 62: 6270–6277.
  CAS PubMed Google Scholar
• Shi Q, Bao S, Maxwell JA, Reese ED, Friedman HS, Bigner DD et al. (2004). Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation. J Biol Chem 279: 52200–52209.
  Article CAS PubMed Google Scholar
• Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987–996.
  Article CAS PubMed Google Scholar
• Troussard AA, Costello P, Yoganathan TN, Kumagai S, Roskelley CD, Dedhar S . (2000). The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene 19: 5444–5452.
  Article CAS PubMed Google Scholar
• Watkins G, Douglas-Jones A, Bryce R, Mansel RE, Jiang WG . (2005). Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes. Prostaglandins Leukot Essent Fatty Acids 72: 267–272.
  Article CAS PubMed Google Scholar
• Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C et al. (2004). Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Cancer Res 64: 1987–1996.
  Article CAS PubMed Google Scholar
• Yiu GK, Chan WY, Ng SW, Chan PS, Cheung KK, Berkowitz RS et al. (2001). SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. Am J Pathol 159: 609–622.
  Article CAS PubMed PubMed Central Google Scholar